Literature DB >> 12236457

Relation of depression diagnoses to 2-year outcomes in cocaine-dependent patients in a randomized continuing care study.

James R McKay1, Helen M Pettinati, Rebecca Morrison, Michael Feeley, Francis D Mulvaney, Robert Gallop.   

Abstract

This study examined the relation between depression diagnoses and outcomes in 132 cocaine-dependent patients who were randomized to relapse prevention (RP) or standard 12-step focused group continuing care and followed for 2 years. Depressed patients attended more treatment sessions and had more cocaine-free urines during treatment than participants without depression, but they drank alcohol more frequently before treatment and during the 18-month posttreatment follow-up. Cocaine outcomes in depressed patients deteriorated to a greater degree after treatment than did cocaine outcomes in patients without depression, particularly in patients in RP who had a current depressive disorder at baseline. The best alcohol outcomes were obtained in nondepressed patients who received RP. The results suggest that extended continuing care treatment may be warranted for cocaine-dependent patients with co-occurring depressive disorders.

Entities:  

Mesh:

Year:  2002        PMID: 12236457

Source DB:  PubMed          Journal:  Psychol Addict Behav        ISSN: 0893-164X


  45 in total

1.  Pilot study of treatment for major depression among women prisoners with substance use disorder.

Authors:  Jennifer E Johnson; Caron Zlotnick
Journal:  J Psychiatr Res       Date:  2012-06-12       Impact factor: 4.791

2.  Effects of independent and substance-induced major depressive disorder on remission and relapse of alcohol, cocaine and heroin dependence.

Authors:  Sharon Samet; Miriam C Fenton; Edward Nunes; Eliana Greenstein; Efrat Aharonovich; Deborah Hasin
Journal:  Addiction       Date:  2012-10-05       Impact factor: 6.526

3.  Time to relapse following treatment for methamphetamine use: a long-term perspective on patterns and predictors.

Authors:  Mary-Lynn Brecht; Diane Herbeck
Journal:  Drug Alcohol Depend       Date:  2014-03-12       Impact factor: 4.492

Review 4.  Behavioral therapies for co-occurring substance use and mood disorders.

Authors:  Kathleen M Carroll
Journal:  Biol Psychiatry       Date:  2004-11-15       Impact factor: 13.382

5.  Psychosocial treatments for cocaine dependence: the role of depressive symptoms.

Authors:  Niklaus Stulz; Michael E Thase; Robert Gallop; Paul Crits-Christoph
Journal:  Drug Alcohol Depend       Date:  2011-03-01       Impact factor: 4.492

6.  Baseline patterns of substance use disorder severity and depression and anxiety symptoms moderate the efficacy of mindfulness-based relapse prevention.

Authors:  Corey R Roos; Sarah Bowen; Katie Witkiewitz
Journal:  J Consult Clin Psychol       Date:  2017-11

7.  Symptoms of anhedonia, not depression, predict the outcome of treatment of cocaine dependence.

Authors:  Paul Crits-Christoph; Steven Wadden; Averi Gaines; Agnes Rieger; Robert Gallop; James R McKay; Mary Beth Connolly Gibbons
Journal:  J Subst Abuse Treat       Date:  2018-06-21

8.  Effects of major depressive disorder and attention-deficit/hyperactivity disorder on the outcome of treatment for cocaine dependence.

Authors:  Frances R Levin; Adam Bisaga; Wilfrid Raby; Efrat Aharonovich; Eric Rubin; John Mariani; Daniel J Brooks; Fatima Garawi; Edward V Nunes
Journal:  J Subst Abuse Treat       Date:  2007-06-15

9.  Clinical efficacy of sertraline alone and augmented with gabapentin in recently abstinent cocaine-dependent patients with depressive symptoms.

Authors:  Michael J Mancino; Janette McGaugh; Mohit P Chopra; Joseph B Guise; Christopher Cargile; D Keith Williams; Jeff Thostenson; Thomas R Kosten; Nichole Sanders; Alison Oliveto
Journal:  J Clin Psychopharmacol       Date:  2014-04       Impact factor: 3.153

10.  Demographic and clinical characteristics of current comorbid psychiatric disorders in a randomized clinical trial for adults with stimulant use disorders.

Authors:  Diane Warden; Katherine Sanchez; Tracy Greer; Thomas Carmody; Robrina Walker; Adriane Dela Cruz; Marisa Toups; Chad Rethorst; Madhukar H Trivedi
Journal:  Psychiatry Res       Date:  2016-09-15       Impact factor: 3.222

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.